Creates a mechanism for international collaboration among World Health Assembly members
The World Health Organization’s working group on low-quality and illegal medicines has drawn up a draft resolution for debate at the 65th World Health Assembly in May 2012.
The draft document backs the WHO’s role in ensuring the public’s access to safe, effective and affordable medicines of acceptable quality, but indicates that the agency should take a back seat on the topic of what have become known as substandard/spurious/falsely labelled/falsified/counterfeit (SSFFC) medical products.
The resolution would create a mechanism for international collaboration among World Health Assembly member states on the topic of SSFFCs to protect public health.
The WHO would continue to share information, create awareness, set standards and provide technical assistance to national governments.
The member state mechanism would identify major needs and challenges in the area of SSFFCs, make policy recommendations and develop tools for the prevention, detection and control of these products.
No progress has been made on finding a solution to the nomenclature of SSFFCs.